Gantz, Ira http://orcid.org/0000-0002-6565-7113
Chen, Menghui
Suryawanshi, Shailaja
Ntabadde, Catherine
Shah, Sukrut
O’Neill, Edward A.
Engel, Samuel S.
Kaufman, Keith D.
Lai, Eseng
Clinical trials referenced in this document:
Documents that mention this clinical trial
DPP-4 Inhibitors and Respiratory Infection: A Systematic Review and Meta-analysis of the Cardiovascular Outcomes Trials
https://doi.org/10.2337/dc20-2018
Evaluating the Cardiovascular Safety of New Medications for Type 2 Diabetes: Time to Reassess?
https://doi.org/10.2337/dc15-2237
A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus
https://doi.org/10.1186/s12933-017-0593-8
Funding for this research was provided by:
Merck
Article History
Received: 4 August 2017
Accepted: 29 August 2017
First Online: 11 September 2017